Ascendis Pharma A/S (ASND)
215.58
+9.75
(+4.74%)
USD |
NASDAQ |
Jan 20, 16:00
215.12
-0.46
(-0.21%)
After-Hours: 20:00
Ascendis Pharma Market Cap: 13.17B for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novo Nordisk A/S | 269.63B |
| Evaxion AS | 29.56M |
| DBV Technologies SA | 571.59M |
| Cellectis SA | 416.35M |
| Biodexa Pharmaceuticals Plc | 1.854M |
Market Cap Related Metrics
| PS Ratio | 18.03 |
| Price | 215.58 |
| Earnings Yield | -1.97% |